Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

An obscure sentence from the interview that didn't get the recognition it deserves:
Daniel O’Connor: As we move ADXS-NEO into the clinic this year, we have a few more intriguing preclinical programs which we have publicly disclosed, and several additional projects for which we are generating preclinical workups. In other words, projects in development that haven't been disclosed yet.

So we know there's a PIII for advanced cervical, we know DO's really really excited about neo, and now we know there are additional projects beyond neo. My guess is infectious disease as he alluded to in the interview.
The success of the PIII will only be the beginning if a very long and prosperous journey for shareholders.